{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:43Z","timestamp":1774538683213,"version":"3.50.1"},"reference-count":19,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos [...]<\/jats:p>","DOI":"10.3390\/cancers13143447","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T10:50:38Z","timestamp":1625827838000},"page":"3447","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Malignant Mesothelioma"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-3828","authenticated-orcid":false,"given":"Daniel L.","family":"Pouliquen","sequence":"first","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-3953","authenticated-orcid":false,"given":"Joanna","family":"Kopecka","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, 10126 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cugliari, G., Catalano, C., Guarrera, S., Allione, A., Casalone, E., Russo, A., Grosso, F., Ferrante, D., Viberti, C., and Aspesi, A. (2020). DNA methylation of FKBP5 as predictor of overall survival in malignant pleural mesothelioma. Cancers, 12.","DOI":"10.3390\/cancers12113470"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cugliari, G., Allione, A., Russo, A., Catalano, C., Casalone, E., Guarrera, S., Grosso, F., Ferrante, D., Sculco, M., and La Vecchia, M. (2021). New DNA methylation signals for malignant pleural mesothelioma risk assessment. Cancers, 13.","DOI":"10.3390\/cancers13112636"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Shrestha, R., Nabavi, N., Volik, S., Anderson, S., Haegert, A., McConeghy, B., Sar, F., Brahmbhatt, S., Bell, R., and Le Bihan, S. (2020). Well-differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma. Cancers, 12.","DOI":"10.3390\/cancers12061568"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Barbarino, M., and Giordano, A. (2021). Assessment of the carcinogenicity of carbon nanotubes in the respiratory system. Cancers, 13.","DOI":"10.3390\/cancers13061318"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dipper, A., Maskell, N., and Bibby, A. (2021). Ancillary diagnostic investigations in malignant pleural mesothelioma. Cancers, 13.","DOI":"10.3390\/cancers13133291"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Moretti, G., Aretini, P., Lessi, F., Mazzanti, C.M., Ak, G., Metintas, M., Lando, C., Filiberti, R.A., Lucchi, M., and Bonotti, A. (2021). Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study. Cancers, 13.","DOI":"10.3390\/cancers13102445"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nader, J.S., Boissard, A., Henry, C., Valo, I., Verri\u00e8le, V., Gr\u00e9goire, M., Coqueret, O., Guette, C., and Pouliquen, D.L. (2020). Cross-species proteomics identifies CAPG and SBP1 as crucial invasiveness biomarkers in rat and human malignant mesothelioma. Cancers, 12.","DOI":"10.3390\/cancers12092430"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Karunakaran, K.B., Yanamala, N., Boyce, G., Becich, M.J., and Ganapathiraju, M.K. (2021). Malignant pleural mesothelioma interactome with 364 novel protein-protein interactions. Cancers, 13.","DOI":"10.3390\/cancers13071660"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Vogl, M., Rosenmayr, A., Bohanes, T., Scheed, A., Brndiar, M., Stubenberger, E., and Ghanim, B. (2021). Biomarkers for malignant pleural mesothelioma\u2014A novel view on inflammation. Cancers, 13.","DOI":"10.3390\/cancers13040658"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Napoli, F., Listi, A., Zambelli, V., Witel, G., Bironzo, P., Papotti, M., Volante, M., Scagliotti, G., and Righi, L. (2021). Pathological characterization of tumor immune microenvironment (TIME) in malignant pleural mesothelioma. Cancers, 13.","DOI":"10.3390\/cancers13112564"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Schiavello, M., Gazzano, E., Bergandi, L., Silvagno, F., Libener, R., Riganti, C., and Aldieri, E. (2021). Identification of redox-sensitive transcription factors as markers of malignant pleural mesothelioma. Cancers, 13.","DOI":"10.3390\/cancers13051138"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Brcic, L., Mathilakathu, A., Walter, R.F.H., Wessolly, M., Mairinger, E., Beckert, H., Kreidt, D., Steinborn, J., Hager, T., and Christoph, D.C. (2021). Digital gene expression analysis of epithelioid and sarcomatoid mesothelioma reveals differences in immunogenicity. Cancers, 13.","DOI":"10.3390\/cancers13081761"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kitajima, K., Maruyama, M., Yokoyama, H., Minami, T., Yokoi, T., Nakamura, A., Hashimoto, M., Kondo, N., Kuribayashi, K., and Kijima, T. (2021). Response to immune checkpoint inhibitor therapy in patients with unresectable recurrent malignant pleural mesothelioma shown by FDG-PET and CT. Cancers, 13.","DOI":"10.3390\/cancers13051098"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lee, D.-S., Carollo, A., Alpert, N., Taioli, E., and Flores, R. (2021). VATS pleurectomy decortication is a reasonable alternative for higher risk patients in the management of malignant pleural mesothelioma: An analysis of short-term outcomes. Cancers, 13.","DOI":"10.3390\/cancers13051068"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Di Gregorio, E., Miolo, G., Saorin, A., Muraro, E., Cangemi, M., Relevant, A., Minatel, E., Trovo, M., Steffan, A., and Corona, G. (2021). Radical hemithoracic radiotherapy induces systemic metabolomics changes that are associated with the clinical outcome of malignant pleural mesothelioma patients. Cancers, 13.","DOI":"10.3390\/cancers13030508"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yang, H., Xu, D., Yang, Z., Yao, F., Zhao, H., Schmid, R.A., and Peng, R.-W. (2020). Systematic analysis of aberrant biochemical networks and potential drug vulnerabilities induced by tumor suppressor loss in malignant pleural mesothelioma. Cancers, 12.","DOI":"10.3390\/cancers12082310"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Anobile, D.P., Bironzo, P., Picca, F., Lingua, M.F., Morena, D., Righi, L., Napoli, F., Papotti, M.G., Pittaro, A., and Di Nicolantonio, F. (2021). Evaluation of the preclinical efficacy of Lurbinectedin in malignant pleural mesothelioma. Cancers, 13.","DOI":"10.3390\/cancers13102332"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kotesha, R., Tonse, R., Rubens, M., Appel, H., Albrecht, F., Kaymin, P., Alley, E.W., Tom, M.C., and Mehta, M.P. (2021). Meta-analysis of survival and development of a prognostic nomogram for malignant pleural mesothelioma treated with systemic chemotherapy. Cancers, 13.","DOI":"10.3390\/cancers13092186"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dulloo, S., Bzura, A., and Fennell, D.A. (2021). Precision therapy for mesothelioma: Feasibility and new opportunities. Cancers, 13.","DOI":"10.3390\/cancers13102347"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/14\/3447\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:28:19Z","timestamp":1760164099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/14\/3447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":19,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["cancers13143447"],"URL":"https:\/\/doi.org\/10.3390\/cancers13143447","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}